ロード中...
Fidaxomicin - the new drug for Clostridium difficile infection
Clostridium difficile is one of the many aetiological agents of antibiotic associated diarrhoea and is implicated in 15-25 per cent of the cases. The organism is also involved in the exacearbation of inflammatory bowel disease and extracolonic manifestations. Due to increase in the incidence of C. d...
保存先:
| 出版年: | Indian J Med Res |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medknow Publications & Media Pvt Ltd
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4510719/ https://ncbi.nlm.nih.gov/pubmed/26112840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0971-5916.159251 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|